Oral iron versus intravenous ferric carboxymaltose in the treatment of iron deficiency anemia in pregnancy: a retrospective study
Şule Yıldız,Engin TürkgeldiArticle info
Oral iron versus intravenous ferric carboxymaltose in the treatment of iron deficiency anemia in pregnancy: a retrospective study. Perinatal Journal 2021;29(3):194-199 DOI: 10.2399/prn.21.0293004
Author(s) Information
Şule Yıldız1 (Project Initiator, Study Designer, Data Collector, Data Analyst, Results Interpreter, Literature Researcher, Manuscript Writer) Engin Türkgeldi1 (Data Collector, Results Interpreter, Literature Researcher, Manuscript Writer, Final Reviewer)1. Department of Obstetrics and Gynecology, School of Medicine, Koç University, Istanbul, Turkey
Correspondence
Şule Yıldız, Department of Obstetrics and Gynecology, School of Medicine, Koç University, Istanbul, Turkey, yildizsuledr@gmail.com
Publication History
- Manuscript Received: September 21, 2021
- Manuscript Accepted: October 31, 2021
- Earlyview Date: October 31, 2021
- Publication date: December 31, 2021
Conflicts of Interest
The authors stated that the standards regarding research and publication ethics, the Personal Data Protection Law and the copyright regulations applicable to intellectual and artistic works are complied with and there is no conflict of interest.
Research funding
This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.